Fig. 8: Regulation of TMAO-induced cardiac hypertrophy.

TMAO promotes SERCA2a interacts with ATG5 complex (ATG12-ATG5-ATG16L1) and activates autophagy, resulting in the autophagy degradation of SERCA2a and elevated cytoplasmic calcium, which finally causes cardiac hypertrophy.